Discrepancies in reporting the CAG repeat lengths for Huntington's disease

Oliver W Quarrell, Olivia Handley, Kirsty O'Donovan, Christine Dumoulin, Maria Ramos-Arroyo, Ida Biunno, Peter Bauer, Margaret Kline, G Bernhard Landwehrmeyer, European Huntington's Disease Network, Zosia Miedzybrodzka

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Huntington's disease results from a CAG repeat expansion within the Huntingtin gene; this is measured routinely in diagnostic laboratories. The European Huntington's Disease Network REGISTRY project centrally measures CAG repeat lengths on fresh samples; these were compared with the original results from 121 laboratories across 15 countries. We report on 1326 duplicate results; a discrepancy in reporting the upper allele occurred in 51% of cases, this reduced to 13.3% and 9.7% when we applied acceptable measurement errors proposed by the American College of Medical Genetics and the Draft European Best Practice Guidelines, respectively. Duplicate results were available for 1250 lower alleles; discrepancies occurred in 40% of cases. Clinically significant discrepancies occurred in 4.0% of cases with a potential unexplained misdiagnosis rate of 0.3%. There was considerable variation in the discrepancy rate among 10 of the countries participating in this study. Out of 1326 samples, 348 were re-analysed by an accredited diagnostic laboratory, based in Germany, with concordance rates of 93% and 94% for the upper and lower alleles, respectively. This became 100% if the acceptable measurement errors were applied. The central laboratory correctly reported allele sizes for six standard reference samples, blind to the known result. Our study differs from external quality assessment (EQA) schemes in that these are duplicate results obtained from a large sample of patients across the whole diagnostic range. We strongly recommend that laboratories state an error rate for their measurement on the report, participate in EQA schemes and use reference materials regularly to adjust their own internal standards.
Original languageEnglish
Pages (from-to)20-26
Number of pages7
JournalEJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.
Volume20
Issue number1
DOIs
Publication statusPublished - 2012

Fingerprint

Huntington Disease
Alleles
Practice Guidelines
Diagnostic Errors
Germany
Genes

Keywords

  • Huntington's disease
  • CAG repeat length
  • standard reference materials

Cite this

Discrepancies in reporting the CAG repeat lengths for Huntington's disease. / Quarrell, Oliver W; Handley, Olivia; O'Donovan, Kirsty; Dumoulin, Christine; Ramos-Arroyo, Maria; Biunno, Ida; Bauer, Peter; Kline, Margaret; Landwehrmeyer, G Bernhard; European Huntington's Disease Network ; Miedzybrodzka, Zosia.

In: EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , Vol. 20, No. 1, 2012, p. 20-26.

Research output: Contribution to journalArticle

Quarrell, OW, Handley, O, O'Donovan, K, Dumoulin, C, Ramos-Arroyo, M, Biunno, I, Bauer, P, Kline, M, Landwehrmeyer, GB, European Huntington's Disease Network & Miedzybrodzka, Z 2012, 'Discrepancies in reporting the CAG repeat lengths for Huntington's disease', EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , vol. 20, no. 1, pp. 20-26. https://doi.org/10.1038/ejhg.2011.136
Quarrell, Oliver W ; Handley, Olivia ; O'Donovan, Kirsty ; Dumoulin, Christine ; Ramos-Arroyo, Maria ; Biunno, Ida ; Bauer, Peter ; Kline, Margaret ; Landwehrmeyer, G Bernhard ; European Huntington's Disease Network ; Miedzybrodzka, Zosia. / Discrepancies in reporting the CAG repeat lengths for Huntington's disease. In: EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. . 2012 ; Vol. 20, No. 1. pp. 20-26.
@article{0fce4c37ad504486ae82475edf48734a,
title = "Discrepancies in reporting the CAG repeat lengths for Huntington's disease",
abstract = "Huntington's disease results from a CAG repeat expansion within the Huntingtin gene; this is measured routinely in diagnostic laboratories. The European Huntington's Disease Network REGISTRY project centrally measures CAG repeat lengths on fresh samples; these were compared with the original results from 121 laboratories across 15 countries. We report on 1326 duplicate results; a discrepancy in reporting the upper allele occurred in 51{\%} of cases, this reduced to 13.3{\%} and 9.7{\%} when we applied acceptable measurement errors proposed by the American College of Medical Genetics and the Draft European Best Practice Guidelines, respectively. Duplicate results were available for 1250 lower alleles; discrepancies occurred in 40{\%} of cases. Clinically significant discrepancies occurred in 4.0{\%} of cases with a potential unexplained misdiagnosis rate of 0.3{\%}. There was considerable variation in the discrepancy rate among 10 of the countries participating in this study. Out of 1326 samples, 348 were re-analysed by an accredited diagnostic laboratory, based in Germany, with concordance rates of 93{\%} and 94{\%} for the upper and lower alleles, respectively. This became 100{\%} if the acceptable measurement errors were applied. The central laboratory correctly reported allele sizes for six standard reference samples, blind to the known result. Our study differs from external quality assessment (EQA) schemes in that these are duplicate results obtained from a large sample of patients across the whole diagnostic range. We strongly recommend that laboratories state an error rate for their measurement on the report, participate in EQA schemes and use reference materials regularly to adjust their own internal standards.",
keywords = "Huntington's disease, CAG repeat length, standard reference materials",
author = "Quarrell, {Oliver W} and Olivia Handley and Kirsty O'Donovan and Christine Dumoulin and Maria Ramos-Arroyo and Ida Biunno and Peter Bauer and Margaret Kline and Landwehrmeyer, {G Bernhard} and {European Huntington's Disease Network} and Zosia Miedzybrodzka",
year = "2012",
doi = "10.1038/ejhg.2011.136",
language = "English",
volume = "20",
pages = "20--26",
journal = "EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Discrepancies in reporting the CAG repeat lengths for Huntington's disease

AU - Quarrell, Oliver W

AU - Handley, Olivia

AU - O'Donovan, Kirsty

AU - Dumoulin, Christine

AU - Ramos-Arroyo, Maria

AU - Biunno, Ida

AU - Bauer, Peter

AU - Kline, Margaret

AU - Landwehrmeyer, G Bernhard

AU - European Huntington's Disease Network

AU - Miedzybrodzka, Zosia

PY - 2012

Y1 - 2012

N2 - Huntington's disease results from a CAG repeat expansion within the Huntingtin gene; this is measured routinely in diagnostic laboratories. The European Huntington's Disease Network REGISTRY project centrally measures CAG repeat lengths on fresh samples; these were compared with the original results from 121 laboratories across 15 countries. We report on 1326 duplicate results; a discrepancy in reporting the upper allele occurred in 51% of cases, this reduced to 13.3% and 9.7% when we applied acceptable measurement errors proposed by the American College of Medical Genetics and the Draft European Best Practice Guidelines, respectively. Duplicate results were available for 1250 lower alleles; discrepancies occurred in 40% of cases. Clinically significant discrepancies occurred in 4.0% of cases with a potential unexplained misdiagnosis rate of 0.3%. There was considerable variation in the discrepancy rate among 10 of the countries participating in this study. Out of 1326 samples, 348 were re-analysed by an accredited diagnostic laboratory, based in Germany, with concordance rates of 93% and 94% for the upper and lower alleles, respectively. This became 100% if the acceptable measurement errors were applied. The central laboratory correctly reported allele sizes for six standard reference samples, blind to the known result. Our study differs from external quality assessment (EQA) schemes in that these are duplicate results obtained from a large sample of patients across the whole diagnostic range. We strongly recommend that laboratories state an error rate for their measurement on the report, participate in EQA schemes and use reference materials regularly to adjust their own internal standards.

AB - Huntington's disease results from a CAG repeat expansion within the Huntingtin gene; this is measured routinely in diagnostic laboratories. The European Huntington's Disease Network REGISTRY project centrally measures CAG repeat lengths on fresh samples; these were compared with the original results from 121 laboratories across 15 countries. We report on 1326 duplicate results; a discrepancy in reporting the upper allele occurred in 51% of cases, this reduced to 13.3% and 9.7% when we applied acceptable measurement errors proposed by the American College of Medical Genetics and the Draft European Best Practice Guidelines, respectively. Duplicate results were available for 1250 lower alleles; discrepancies occurred in 40% of cases. Clinically significant discrepancies occurred in 4.0% of cases with a potential unexplained misdiagnosis rate of 0.3%. There was considerable variation in the discrepancy rate among 10 of the countries participating in this study. Out of 1326 samples, 348 were re-analysed by an accredited diagnostic laboratory, based in Germany, with concordance rates of 93% and 94% for the upper and lower alleles, respectively. This became 100% if the acceptable measurement errors were applied. The central laboratory correctly reported allele sizes for six standard reference samples, blind to the known result. Our study differs from external quality assessment (EQA) schemes in that these are duplicate results obtained from a large sample of patients across the whole diagnostic range. We strongly recommend that laboratories state an error rate for their measurement on the report, participate in EQA schemes and use reference materials regularly to adjust their own internal standards.

KW - Huntington's disease

KW - CAG repeat length

KW - standard reference materials

U2 - 10.1038/ejhg.2011.136

DO - 10.1038/ejhg.2011.136

M3 - Article

VL - 20

SP - 20

EP - 26

JO - EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.

JF - EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.

SN - 1018-4813

IS - 1

ER -